Cargando…
Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis
BACKGROUND: Malignant glioma is the most common intracranial malignant tumor with the highest mortality. In the era of immunotherapy, it is important to determine what type of immunotherapy provides the best chance of survival. METHOD: Here, the efficacy and safety of immunotherapy in high-grade gli...
Autores principales: | Guo, Baofeng, Zhang, Shengnan, Xu, Libo, Sun, Jicheng, Chan, Wai-Lun, Zheng, Pengfei, Zhang, Jinnan, Zhang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357294/ https://www.ncbi.nlm.nih.gov/pubmed/37483593 http://dx.doi.org/10.3389/fimmu.2023.966696 |
Ejemplares similares
-
Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas
por: Zhang, Po, et al.
Publicado: (2022) -
Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
por: Hu, Jinyang, et al.
Publicado: (2020) -
Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022) -
Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023) -
Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
por: Kuang, Yirui, et al.
Publicado: (2023)